MapLight Therapeutics, Inc.·4

Feb 12, 5:45 PM ET

Garnett Timothy John 4

4 · MapLight Therapeutics, Inc. · Filed Feb 12, 2026

Research Summary

AI-generated summary of this filing

Updated

MapLight (MPLT) Director Timothy Garnett Buys 14,124 Shares

What Happened
Timothy J. Garnett, a director of MapLight Therapeutics, acquired 14,124 shares in an open-market purchase on February 10, 2026. The reported weighted-average price was $17.89 per share for a total value of $252,678. This was a purchase (buy) rather than a sale or option exercise.

Key Details

  • Transaction date: 2026-02-10; Form 4 filed: 2026-02-12 (timely filing).
  • Shares purchased: 14,124; reported weighted-average price: $17.89; total reported value: $252,678.
  • Price range: purchases occurred at prices from $17.76 to $17.90 (footnote F1 — weighted avg reported; breakdown available on request).
  • Shares are held by the "Timothy J Garnett Revocable Trust Dated U/A 09/22/2021"; Garnett is sole trustee with voting and dispositive power (footnote F2).
  • The filing did not disclose the total number of shares owned by Garnett after this transaction in the information provided here.

Context
This was an open-market buy (not an option exercise, gift, or 10b5-1 sale plan). Purchases by insiders can be of interest to investors as one data point on insider sentiment, but the filing itself does not state Garnett’s motivations.

Insider Transaction Report

Form 4
Period: 2026-02-10
Transactions
  • Purchase

    Voting Common Stock

    [F1][F2]
    2026-02-10$17.89/sh+14,124$252,67814,124 total(indirect: See footnote)
Holdings
  • Voting Common Stock

    49,525
Footnotes (2)
  • [F1]The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $17.76 to $17.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.
  • [F2]The shares are held by the Timothy J Garnett Revocable Trust Dated U/A 09/22/2021, of which the Reporting Person is the sole trustee and has voting and dispositive power.
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact|2026-02-12

Documents

1 file
  • 4
    form4-02122026_050203.xmlPrimary